Table 1.
CT-induced change in morphology
| Condition | % Affected cells (n = 150–250, ±5%) |
|---|---|
| Single Interference | |
| Eps15Δ95-295 | 98.5 |
| Cav1S80E | 97.1 |
| Arf6Q67L | 98.4 |
| Arf6T27N | 93.9 |
| Multiple Interferences | |
| Arf6Q67L/Cav1S80E | 88 |
| Eps15Δ95-295/Arf6Q67L | 96 |
| Dyn1K44A | 85 |
| Eps15Δ95-295/Cav1S80E | 96.4 |
| Arf6Q67L/Dyn2K44A | 76.8 |
In each case, the concentration of CT used (of EC95 200 pM) was such that even partial inhibition of endocytic entry should result in a detectable effect on toxicity. In addition, overexpression of two other dominant negative mutants of caveolin or preincubation with genistein did not protect Y-1 cells against CT-induced cell shape changes (Fig. 6A and B). Representative fluorescence (displayed in inverted monochrome scale) and phase contrast images of these conditions are shown in Fig. 7 (Supplement).